{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:07:12Z","timestamp":1788307632735,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment of in-stent restenosis (ISR) remains a significant challenge. Current options include repeat stenting or drug-coated balloons. However, there is a paucity of data regarding vascular healing after these strategies. We, aimed to compare optical coherence tomography (OCT)-based vessel healing after treatment with paclitaxel-coated balloons (PCB) or everolimus-eluting stents (EES).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An OCT substudy (baseline and 6\u20139\u2009months) of patients from RIBS IV and RIBS V, two prospective multicenter, randomized controlled clinical trials comparing PCB vs. EES in patients with ISR was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixty-four patients were included (30 PCB and 34 EES). There were no differences in the baseline or angiographic characteristics between groups. Both groups had the same proportion of drug-eluting and bare-metal stent (BMS) ISR. Baseline OCT analysis did not show differences in the qualitative characteristics of the ISR nor the restenotic tissue burden. Follow-up OCT showed a larger mean lumen area in the EES group (6.03\u2009\u00b1\u20091.5 vs. 5.24\u2009\u00b1\u20091.3\u2009mm\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.043) but no difference in angiographic restenosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.66). Percentage tissue coverage was higher with PCB vs. EES (26\u2009\u00b1\u200913 vs. 19\u2009\u00b1\u200911%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.031). EES-treated ISR more frequently had uncovered struts at follow-up [21 (72%) vs. 12 (44%);\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.034]. Tissue covering struts more frequently had a high backscatter structure after PCB [21 (78%) vs. 16 (55%);\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.07].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with EES, ISR treated with PCB demonstrated more strut coverage with mainly high backscattering tissue. Larger OCT-defined neointimal proliferation in PCB-treated ISR did not translate into higher angiographic restenosis rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001189","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T03:00:32Z","timestamp":1665716432000},"page":"609-617","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography"],"prefix":"10.1097","volume":"33","author":[{"given":"Angela","family":"McInerney","sequence":"first","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Salazar","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"P\u00e9rez-Vizcayno","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"},{"name":"Fundaci\u00f3n Interhospitalaria para la Investigaci\u00f3n Cardiovascular (FIC)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Jimenez-Quevedo","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Jim\u00e9nez-Valero","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario La Paz, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Brugaletta","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednic, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Romaguera","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Bellvitge, L\u2019Hospitalet de Llobregat, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Nombela-Franco","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Travieso-Gonzalez","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Jer\u00f3nimo-Baza","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Tirado-Conte","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fern\u00e1ndez-Ortiz","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Escaned","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alfonso","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario de la Princesa, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Macaya","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Gonzalo","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Intervencionista, Hospital Universitario Cl\u00ednico San Carlos, IdISSC, Universidad Complutense"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heartjnl-2013-304933","article-title":"Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.","volume":"100","author":"Cassese","year":"2014","journal-title":"Heart"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ahj.2009.06.004","article-title":"Optical coherence tomography patterns of stent restenosis.","volume":"158","author":"Gonzalo","year":"2009","journal-title":"Am Heart J"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1161\/CIRCULATIONAHA.110.988436","article-title":"Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.","volume":"123","author":"Kang","year":"2011","journal-title":"Circulation"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization.","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.115.019071","article-title":"Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography.","volume":"133","author":"Taniwaki","year":"2016","journal-title":"Circulation"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","article-title":"Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).","volume":"136","author":"Adriaenssens","year":"2017","journal-title":"Circulation"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","article-title":"A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial.","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"681.e1","DOI":"10.1016\/j.ahj.2005.10.014","article-title":"Value of the American College of Cardiology\/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial.","volume":"151","author":"Alfonso","year":"2006","journal-title":"Am Heart J"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","article-title":"Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.","volume":"100","author":"Mehran","year":"1999","journal-title":"Circulation"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","article-title":"In-stent neoatherosclerosis: a final common pathway of late stent failure.","volume":"59","author":"Park","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014.","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1093\/eurheartj\/ehz594","article-title":"Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).","volume":"41","author":"Giacoppo","year":"2019","journal-title":"Eur Heart J"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jcin.2012.12.132","article-title":"Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.","volume":"6","author":"Agostoni","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4244\/EIJV10I4A77","article-title":"Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.","volume":"10","author":"Adriaenssens","year":"2014","journal-title":"EuroIntervention"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijcard.2016.07.110","article-title":"Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: optical coherence tomography and histopathology validation study.","volume":"221","author":"Imanaka","year":"2016","journal-title":"Int J Cardiol"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jcmg.2012.01.024","article-title":"Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.","volume":"5","author":"Kim","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"R18-20250729","first-page":"89","article-title":"Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug-eluting stent restenosis swine model.","volume":"88","author":"Li","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"Suppl C","key":"R19-20250729","first-page":"C7","article-title":"Pathophysiology of vascular healing and stent mediated arterial injury.","volume":"4","author":"Nakazawa","year":"2008","journal-title":"EuroIntervention"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2010.05.066","article-title":"Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"63","author":"Palmerini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","article-title":"Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.","volume":"5","author":"Scheller","year":"2012","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:05:37Z","timestamp":1753812337000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001189","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}